Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter

被引:0
作者
Ye Meng
Lu Zong
机构
[1] The First Affiliated Hospital of USTC,
[2] Division of Life Sciences and Medicine,undefined
[3] University of Science and Technology of China,undefined
来源
Cellular & Molecular Biology Letters | 2019年 / 24卷
关键词
Sterol regulatory element-binding protein 2; Estradiol; Transcription regulation; Lipid metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 159 条
[1]  
Glovaci D(2019)Epidemiology of diabetes mellitus and cardiovascular disease Curr Cardiol Rep 21 21-228
[2]  
Fan W(2017)Obesity and cardiovascular diseases Minerva Med 108 212-1138
[3]  
Wong ND(2010)Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project J Women's Health (Larchmt) 19 1129-1114
[4]  
Kachur S(2016)Shared risk factors in cardiovascular disease and Cancer Circulation 133 1104-162
[5]  
Lavie CJ(2017)Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: insights from a large US managed-care population Clin Cardiol 40 155-686
[6]  
de Schutter A(2017)Absolute risk of cardiovascular disease events and blood pressure- and lipid-lowering therapy in Australia Med J Aust 206 51-118
[7]  
Milani RV(2017)The role of statins in the activation of Heme Oxygenase-1 in cardiovascular diseases Curr Drug Targets 18 674-734
[8]  
Ventura HO(2016)Statins alone or polypill for primary prevention of cardiovascular diseases J Diabetes Metab Disord 15 55-2919
[9]  
Hayashi T(2018)The risk of cardiovascular disease, fracture, dementia, and Cancer after long-term hormone therapy in Perimenopausal and postmenopausal women Am Fam Physician 98 117-2742
[10]  
Farrell MA(2013)Is there a role for menopausal hormone therapy (MHT) for cardiovascular disease prevention in select postmenopausal women? Curr Treat Options Cardiovasc Med 15 722-984